Cellectar Biosciences - 48 Year Dividend History | CLRB

Historical dividend payout and yield for Cellectar Biosciences (CLRB) since 1971. The current TTM dividend payout for Cellectar Biosciences (CLRB) as of June 17, 2019 is $0.00. The current dividend yield for Cellectar Biosciences as of June 17, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.021B $0.000B
Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a novel phospholipid ether platform technology as a targeted delivery and retention vehicle. Cellectar Biosciences Inc., formerly known as Novelos Therapeutics, Inc., is headquartered in Madison, Wisconsin.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $145.051B 28.16
Medtronic (MDT) Ireland $130.762B 18.68
Stryker (SYK) United States $72.931B 26.03
Baxter (BAX) United States $39.757B 25.06
Zimmer Biomet Holdings (ZBH) United States $24.054B 15.45
Smith & Nephew SNATS (SNN) United Kingdom $18.710B 0.00
ResMed (RMD) United States $16.933B 32.35
Hill-Rom Holdings (HRC) United States $6.972B 21.14
Perrigo (PRGO) Ireland $5.872B 9.93
Phibro Animal Health (PAHC) United States $1.174B 17.58
LeMaitre Vascular (LMAT) United States $0.513B 24.82
Meridian Bioscience (VIVO) United States $0.497B 15.18
Utah Medical Products (UTMD) United States $0.300B 20.78
Owens & Minor (OMI) United States $0.177B 3.75
United-Guardian (UG) United States $0.087B 19.15